GlassScriptPhysician profile
Adam Darrell Brown
NPI 1285328286
$1,717.33
in general payments reported to CMS, 2019-2025
13 companies · $872 in 2025
The $872 reported for 2025 was more than what 78% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $235 · 2024: $610 · 2025: $872.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,097 · Education: $620.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,097.35 |
| Education | $619.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $619.98 | 2024-2025 | Actis |
| Stryker Corporation | $172.01 | 2025 | Dart-Fire |
| Medtronic, INC. | $167.27 | 2025 | In.Pact Admiral |
| Organogenesis INC. | $143.38 | 2023-2025 | Puraply Antimicrobial, Apligraf |
| Novastep INC. | $123.38 | 2024 | Nexis |
| Seapearl East, INC | $113.42 | 2023 | |
| Medline Industries LP | $112.18 | 2024 | |
| Paratek Pharmaceuticals, INC. | $62.02 | 2024-2025 | Nuzyra |
| Mimedx Group, INC. | $59.70 | 2024-2025 | |
| Bone Support INC. | $58.63 | 2025 | Ceramentbone Void Filler, Cerament G |
| Reprise Biomedical, INC. | $48.14 | 2024 | Miro3d |
| Kerecis Limited | $29.95 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Advanced Oxygen Therapy INC. | $7.27 | 2024 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.